IN8bio, Inc. (INAB)
NASDAQ: INAB · IEX Real-Time Price · USD
1.020
-0.090 (-8.11%)
Apr 15, 2024, 4:00 PM EDT - Market closed
IN8bio Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for IN8bio stock have an average target of 9.30, with a low estimate of 5.00 and a high estimate of 14. The average target predicts an increase of 811.76% from the current stock price of 1.02.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for IN8bio stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 5 | 5 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $14 | Strong Buy | Reiterates | $14 | +1,272.55% | Apr 10, 2024 |
| Laidlaw & Co. | Laidlaw & Co. | Strong Buy Initiates $7.5 | Strong Buy | Initiates | $7.5 | +635.29% | Mar 18, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $14 | Strong Buy | Reiterates | $14 | +1,272.55% | Mar 15, 2024 |
| JonesTrading | JonesTrading | Strong Buy Initiates $5 | Strong Buy | Initiates | $5 | +390.20% | Mar 13, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $14 | Strong Buy | Reiterates | $14 | +1,272.55% | Nov 13, 2023 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
9.38M
EPS This Year
-0.69
from -1.00
EPS Next Year
-0.58
from -0.69
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | 29.0M | 150.2M | 244.1M | 328.2M |
| Avg | n/a | 9.4M | 48.6M | 237.1M | 318.8M |
| Low | n/a | n/a | n/a | 227.8M | 306.3M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | 1,500.1% | 402.0% | 38.4% |
| Avg | - | - | 418.1% | 387.6% | 34.5% |
| Low | - | - | - | 368.5% | 29.2% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -0.65 | -0.44 | 0.80 | 1.80 | 2.06 |
| Avg | -0.69 | -0.58 | -0.23 | 1.74 | 2.00 |
| Low | -0.70 | -0.84 | -1.03 | 1.68 | 1.92 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | 18.0% |
| Avg | - | - | - | - | 14.6% |
| Low | - | - | - | - | 10.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.